Cargando…
Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes
Usual community pharmacy workflow, whereby patients might see a pharmacist at the end of the dispensing process, is not conducive to proactive patient-centred care. The objective of this study was to evaluate the impact of the “Pharmacist First” (P1st) workflow model on blood pressure and glycemic c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581804/ https://www.ncbi.nlm.nih.gov/pubmed/34777646 http://dx.doi.org/10.1177/17151635211016498 |
_version_ | 1784596882196004864 |
---|---|
author | So, Randy Al Hamarneh, Yazid N. Oleksyn, Carlene Purschke, Mary Tsuyuki, Ross T. |
author_facet | So, Randy Al Hamarneh, Yazid N. Oleksyn, Carlene Purschke, Mary Tsuyuki, Ross T. |
author_sort | So, Randy |
collection | PubMed |
description | Usual community pharmacy workflow, whereby patients might see a pharmacist at the end of the dispensing process, is not conducive to proactive patient-centred care. The objective of this study was to evaluate the impact of the “Pharmacist First” (P1st) workflow model on blood pressure and glycemic control in patients with hypertension and/or diabetes. This retrospective review was set in 2 community pharmacies that use the P1st model in the Greater Edmonton Region. The population entailed patients with hypertension and/or type 1 or 2 diabetes who received care via the P1st workflow model. The P1st workflow model places the patient in immediate contact with the pharmacist. The pharmacist first assesses prescription appropriateness, reviews relevant laboratory tests, discusses chronic disease control and addresses any questions or concerns the patient has before passing the prescription to be filled by a technician. This allows issues or concerns to be identified and addressed up front, rather than waiting until the prescription is filled and the patient is ready to leave the pharmacy. The primary outcome assessed in this study was change in blood pressure and/or A1C from baseline to the last follow-up visit. We reviewed 215 patient records. The mean age was 69.4 years (standard deviation 12.5), 51.2% of patients were male, 57.7% had hypertension, 5.6% had diabetes, and 36.7% had both. Median follow-up time was 4.2 months (interquartile range 2.5-9.3). In 203 patients with hypertension, systolic blood pressure was reduced from 139.83 mmHg to 131.26 mmHg (p < 0.001) and diastolic blood pressure from 80.26 mmHg to 76.86 mmHg (p < 0.001). In 87 patients with diabetes, A1C changed from 7.4% to 7.2% (p = ns). The P1st workflow model demonstrated significant improvements in blood pressure. Further investigation is needed to evaluate the effectiveness of this model with a control group, longer follow-up and evaluation of the patient experience. |
format | Online Article Text |
id | pubmed-8581804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-85818042021-11-12 Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes So, Randy Al Hamarneh, Yazid N. Oleksyn, Carlene Purschke, Mary Tsuyuki, Ross T. Can Pharm J (Ott) Research and Clinical Usual community pharmacy workflow, whereby patients might see a pharmacist at the end of the dispensing process, is not conducive to proactive patient-centred care. The objective of this study was to evaluate the impact of the “Pharmacist First” (P1st) workflow model on blood pressure and glycemic control in patients with hypertension and/or diabetes. This retrospective review was set in 2 community pharmacies that use the P1st model in the Greater Edmonton Region. The population entailed patients with hypertension and/or type 1 or 2 diabetes who received care via the P1st workflow model. The P1st workflow model places the patient in immediate contact with the pharmacist. The pharmacist first assesses prescription appropriateness, reviews relevant laboratory tests, discusses chronic disease control and addresses any questions or concerns the patient has before passing the prescription to be filled by a technician. This allows issues or concerns to be identified and addressed up front, rather than waiting until the prescription is filled and the patient is ready to leave the pharmacy. The primary outcome assessed in this study was change in blood pressure and/or A1C from baseline to the last follow-up visit. We reviewed 215 patient records. The mean age was 69.4 years (standard deviation 12.5), 51.2% of patients were male, 57.7% had hypertension, 5.6% had diabetes, and 36.7% had both. Median follow-up time was 4.2 months (interquartile range 2.5-9.3). In 203 patients with hypertension, systolic blood pressure was reduced from 139.83 mmHg to 131.26 mmHg (p < 0.001) and diastolic blood pressure from 80.26 mmHg to 76.86 mmHg (p < 0.001). In 87 patients with diabetes, A1C changed from 7.4% to 7.2% (p = ns). The P1st workflow model demonstrated significant improvements in blood pressure. Further investigation is needed to evaluate the effectiveness of this model with a control group, longer follow-up and evaluation of the patient experience. SAGE Publications 2021-05-27 /pmc/articles/PMC8581804/ /pubmed/34777646 http://dx.doi.org/10.1177/17151635211016498 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research and Clinical So, Randy Al Hamarneh, Yazid N. Oleksyn, Carlene Purschke, Mary Tsuyuki, Ross T. Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes |
title | Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes |
title_full | Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes |
title_fullStr | Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes |
title_full_unstemmed | Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes |
title_short | Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes |
title_sort | impact of a “pharmacist first” innovative workflow plan in patients with hypertension and/or diabetes |
topic | Research and Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581804/ https://www.ncbi.nlm.nih.gov/pubmed/34777646 http://dx.doi.org/10.1177/17151635211016498 |
work_keys_str_mv | AT sorandy impactofapharmacistfirstinnovativeworkflowplaninpatientswithhypertensionandordiabetes AT alhamarnehyazidn impactofapharmacistfirstinnovativeworkflowplaninpatientswithhypertensionandordiabetes AT oleksyncarlene impactofapharmacistfirstinnovativeworkflowplaninpatientswithhypertensionandordiabetes AT purschkemary impactofapharmacistfirstinnovativeworkflowplaninpatientswithhypertensionandordiabetes AT tsuyukirosst impactofapharmacistfirstinnovativeworkflowplaninpatientswithhypertensionandordiabetes |